In last trading session, NRX Pharmaceuticals Inc (NASDAQ:NRXP) saw 0.43 million shares changing hands with its beta currently measuring 1.13. Company’s recent per share price level of $3.02 trading at $0.03 or 1.00% at ring of the bell on the day assigns it a market valuation of $36.52M. That closing price of NRXP’s stock is at a discount of -142.72% from its 52-week high price of $7.33 and is indicating a premium of 63.58% from its 52-week low price of $1.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.82 million shares which gives us an average trading volume of 1.14 million if we extend that period to 3-months.
For NRX Pharmaceuticals Inc (NRXP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.29 in the current quarter.
NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information
Upright in the green during last session for gaining 1.00%, in the last five days NRXP remained trading in the red while hitting it’s week-highest on Tuesday, 01/28/25 when the stock touched $3.02 price level, adding 21.15% to its value on the day. NRX Pharmaceuticals Inc’s shares saw a change of 37.27% in year-to-date performance and have moved -6.21% in past 5-day. NRX Pharmaceuticals Inc (NASDAQ:NRXP) showed a performance of 97.39% in past 30-days. Number of shares sold short was 0.68 million shares which calculate 4.8 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 2 to the stock, which implies a fall of -51.0% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 2. It follows that stock’s current price would jump 33.77% in reaching the projected high whereas dropping to the targeted low would mean a gain of 33.77% for stock’s current value.
NRX Pharmaceuticals Inc (NRXP) estimates and forecasts
Statistics highlight that NRX Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 31.88% of value to its shares in past 6 months, showing an annual growth rate of 52.70% while that of industry is 17.20. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
And 1 analysts are in estimates of company making revenue of 5M in the next quarter.
NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders
Insiders are in possession of 23.56% of company’s total shares while institution are holding 6.05 percent of that, with stock having share float percentage of 7.92%. Investors also watch the number of corporate investors in a company very closely, which is 6.05% institutions for NRX Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, AdvisorShares Trust-AdvisorShares Psychedelics ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 318.5 shares of worth $0.96 million or 2.63% of the total outstanding shares. The later fund manager was in possession of 193.42 shares on Sep 30, 2024 , making its stake of worth around $0.58 million in the company or a holder of 1.60% of company’s stock.
